Autonomix Medical (AMIX) Total Debt (2023 - 2024)

Autonomix Medical's (AMIX) quarterly Total Debt came in at $1.1 million in Q4 2024, down 22.31% year-on-year from $1.5 million in Q1 2024, and down 22.31% on a QoQ basis from $1.5 million in Q4 2023.

Autonomix Medical (AMIX) Total Debt (2023 - 2024) Analysis & Trends

Autonomix Medical (AMIX) has 2 years of Total Debt data on file, last reported at $1.1 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 34.05 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 14.72 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 27.96 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 11.03 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 598.50 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.48 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 10.14 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.18 Bn
10 Autonomix Medical 1.03 Mn 1.03 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 1.13 Mn
Dec 31, 2023 1.46 Mn